Tokiniwa H - Search Results

1

Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.

Tokiniwa H, Horiguchi J, Takata D, Kikuchi M, Rokutanda N, Nagaoka R, Sato A, Odawara H, Tozuka K, Oyama T, Takeyoshi I. Tokiniwa H, et al. Breast Cancer. 2012 Oct;19(4):309-14. doi: 10.1007/s12282-011-0291-4. Epub 2011 Jul 2. Breast Cancer. 2012. PMID: 21725655

2

Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsy.

Rokutanda N, Horiguchi J, Koibuchi Y, Nagaoka R, Sato A, Odawara H, Tokiniwa H, Iino Y, Hirato J, Takeyoshi I. Rokutanda N, et al. Among authors: tokiniwa h. Breast Cancer. 2009;16(2):162-5. doi: 10.1007/s12282-008-0089-1. Epub 2009 Feb 26. Breast Cancer. 2009. PMID: 19242778

3

Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience.

Horiguchi J, Oyama T, Takata D, Rokutanda N, Nagaoka R, Odawara H, Tokiniwa H, Tozuka K, Kikuchi M, Sato A, Takeyoshi I. Horiguchi J, et al. Among authors: tokiniwa h. Anticancer Res. 2011 Sep;31(9):3041-6. Anticancer Res. 2011. PMID: 21868556

4

Variation in use of estrogen receptor-α gene promoters in breast cancer compared by quantification of promoter-specific messenger RNA.

Higuchi T, Gohno T, Nagatomo T, Tokiniwa H, Niwa T, Horiguchi J, Oyama T, Takeyoshi I, Hayashi S. Higuchi T, et al. Among authors: tokiniwa h. Clin Breast Cancer. 2014 Aug;14(4):249-57. doi: 10.1016/j.clbc.2013.10.015. Epub 2013 Oct 26. Clin Breast Cancer. 2014. PMID: 24332559

5

Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer.

Tozuka K, Horiguchi J, Takata D, Rokutanda N, Nagaoka R, Tokiniwa H, Kikuchi M, Satou A, Takei H, Takeyoshi I. Tozuka K, et al. Among authors: tokiniwa h. Mol Clin Oncol. 2013 Jan;1(1):93-99. doi: 10.3892/mco.2012.4. Epub 2012 Jul 26. Mol Clin Oncol. 2013. PMID: 24649129 Free PMC article.

6

APOBEC3B high expression status is associated with aggressive phenotype in Japanese breast cancers.

Tsuboi M, Yamane A, Horiguchi J, Yokobori T, Kawabata-Iwakawa R, Yoshiyama S, Rokudai S, Odawara H, Tokiniwa H, Oyama T, Takeyoshi I, Nishiyama M. Tsuboi M, et al. Among authors: tokiniwa h. Breast Cancer. 2016 Sep;23(5):780-8. doi: 10.1007/s12282-015-0641-8. Epub 2015 Oct 17. Breast Cancer. 2016. PMID: 26476745

7

[A phase I study of combination therapy with capecitabine and paclitaxel for patients with inoperable breast cancer or recurrent breast cancer].

Horiguchi J, Koibuchi Y, Rokutanda N, Nagaoka R, Kikuchi M, Sato A, Odawara H, Ishikawa Y, Tokiniwa H, Iino Y, Takeyoshi I. Horiguchi J, et al. Among authors: tokiniwa h. Gan To Kagaku Ryoho. 2008 Nov;35(11):1877-81. Gan To Kagaku Ryoho. 2008. PMID: 19011335 Clinical Trial. Japanese.

8

Papillary lesions of the breast diagnosed using core needle biopsies.

Tokiniwa H, Horiguchi J, Takata D, Kikuchi M, Rokutanda N, Nagaoka R, Sato A, Odawara H, Tozuka K, Oyama T, Takeyoshi I. Tokiniwa H, et al. Exp Ther Med. 2011 Nov;2(6):1069-1072. doi: 10.3892/etm.2011.332. Epub 2011 Aug 11. Exp Ther Med. 2011. PMID: 22977622 Free PMC article.

9

[Phase I study of sequential S-1 and cyclophosphamide therapy in patients with metastatic breast cancer].

Horiguchi J, Takata D, Rokutanda N, Nagaoka R, Tokiniwa H, Odawara H, Kikuchi M, Sato A, Takeyoshi I. Horiguchi J, et al. Among authors: tokiniwa h. Gan To Kagaku Ryoho. 2013 Sep;40(9):1175-80. Gan To Kagaku Ryoho. 2013. PMID: 24047774 Clinical Trial. Japanese.

10

Clinicopathological Features of Cases with Primary Breast Cancer not Identified by 18F-FDG-PET.

Fujii T, Yajima R, Tsuboi M, Higuchi T, Obayashi S, Tokiniwa H, Nagaoka R, Takata D, Horiguchi J, Kuwano H. Fujii T, et al. Among authors: tokiniwa h. Anticancer Res. 2016 Jun;36(6):3019-22. Anticancer Res. 2016. PMID: 27272820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters